Trial ID or NCT#

NCT0662038

Status

NOT RECRUITING

Purpose

This is an open-label, multi-center, extension study for patients with IPF who complete a qualifying InterMune clinical trial of pirfenidone. The purpose of this study is to obtain additional safety data for pirfenidone 2403 mg/day in patients with IPF who complete a qualifying InterMune clinical trial of pirfenidone.

Investigator(s)

Contact us to find out if this trial is right for you.

CONTACT

Susan Jacobs
(650) 725-8083